A new FTC report claims that pharmacy benefit managers generated $7.3bn by marking up specialty generics used to treat diseases like cancer and HIV. R&D Sponsored ...

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

The FTC has been scrutinizing the pharmacy benefit management industry since 2022, asking six of the industry's largest players to report key details on their business practices. Last summer ...

Al Roberts and Travis Hale, the owners of Remington Drug Company in Remington, Va., hosted Andrew Ferguson, chair of the ...

The number of retail pharmacies in Ohio last year dropped below 2,000, according to a data tool made public last month by the Ohio Board of Pharmacy.

A pharmacy benefit manager negotiates prices with wholesalers, sets reimbursement rates on drugs and compiles the lists of which medicines an insurer will cover. But critics describe the industry as ...

WASHINGTON (Reuters) - President Donald Trump fired the two Democratic commissioners at the U.S. Federal Trade Commission on ...

The U.S. House is renewing a push to take on pharmacy benefit managers that play an important ... PBMs have been targeted by Congress and the Federal Trade Commission for their powerful role ...

This system has come under scrutiny from the Federal Trade Commission, which in a July 2024 report called pharmacy benefit managers “the powerful middlemen inflating drug costs and squeezing ...